Neurotechnology Ventures

[Class Content]   [Fall 2014]  [Fall 2013]  [Fall 2012]  [Fall 2011]  [Fall 2010]  [Fall 2009]  [Fall 2008]  

MIT Course Numbers: MAS.961 ~ 9.917 ~ HST.588
Instructors: J. Bonsen ~ E.S. Boyden ~ R.G. Ellis-Behnke
Units: H-level ~ 2-0-4 Units
Time: Tuesdays, 7-9pm (8-10pm after daylight savings begins); Begins Tues Feb 6, 2007
Place: Room 46-3002
Special note: Class sessions will be live link to University of Hong Kong


Neurotechnology Ventures is a new seminar and project-oriented course on the challenges of envisioning, planning, and building startups to bring neuroengineering innovations to the world.

Each 2-hour class begins with a survey of a broad topic area, and continues with a live-case study of a current, specific, development or commercialization effort in that area. Explorations will cover a broad array of issues ranging from the deeply technical, to the analysis of market realities.

Topics Include: Neuroimaging, Neurology/Psychiatry Diagnosis, Rehabilitation, Neurosurgery, Neuropharmacology, Brain Stimulation, Prosthetics, Sensory and Motor Augmentation, Regenerative Neuromedicine, and more.

Limited Enrollment: Open to advanced students by permission of instructors. Email two paragraphs summarizing your: (1) Professional Skills & Experience, and (2) Inventive/Entrepreneurial Aspirations.

Student Project: Students will work in teams to analyze an opportunity and create a business plan executive summary to solve a major problem through neurotechnology. The project will develop throughout the term, culminating in a final presentation. We expect that some projects may go on to become successful ventures.


Tues., Feb. 6 Overview of class, goals, networking

Tues., Feb. 13 Shai Gozani, Founder & CEO of NeuroMetrix, Noninvasive Neurological Diagnostic and Therapeutic Solutions

Tues., Feb. 20 first teambuilding event

Tues., Feb. 27 Steve Kelly, CEO of Myomo, NeuroRobotics for stroke therapy

Tues., Mar. 6 Rutledge Ellis-Behnke, Jerry Schneider, Peptides, Clotting, and Spinal Cord Injury

Tues., Mar. 13 First round of presentations

Tues., Mar. 20 Richard Wurtman, MIT professor, Neuropharmaceuticals and Clinical Trials in Academia

Tues., Mar. 27 Beran Rose, Boston Scientific, Corporate R&D in Neurotechnology

Tues., Apr. 3rd Daniel Lee, Biogen IDEC, Multiple Sclerosis Therapy

Tues., Apr. 24th Carl Marci, MGH Psychiatry, Emotion, Psychiatry, and Neuromarketing

Thurs., May 3 Michael Merzenich, UCSF professor, co-founder of Scientific Learning and Posit Science, in room E15-209 (note changed date!).

Tues., May 15 Final student presentations

(C) 2007-present, Bonsen, Boyden, Ellis-Behnke